Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Capital Expenditures (2016 - 2025)

National Research's Capital Expenditures history spans 16 years, with the latest figure at $10.4 million for Q4 2025.

  • For Q4 2025, Capital Expenditures rose 1083.74% year-over-year to $10.4 million; the TTM value through Dec 2025 reached $10.7 million, up 589.82%, while the annual FY2025 figure was $10.7 million, 589.82% up from the prior year.
  • Capital Expenditures for Q4 2025 was $10.4 million at National Research, up from -$5.7 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $14.0 million in Q4 2023 and bottomed at -$6.8 million in Q3 2024.
  • The 5-year median for Capital Expenditures is $1.4 million (2021), against an average of $1.5 million.
  • The largest YoY upside for Capital Expenditures was 1510.15% in 2023 against a maximum downside of 912.39% in 2023.
  • A 5-year view of Capital Expenditures shows it stood at -$2.8 million in 2021, then soared by 130.77% to $867000.0 in 2022, then skyrocketed by 1510.15% to $14.0 million in 2023, then plummeted by 107.58% to -$1.1 million in 2024, then skyrocketed by 1083.74% to $10.4 million in 2025.
  • Per Business Quant, the three most recent readings for NRC's Capital Expenditures are $10.4 million (Q4 2025), -$5.7 million (Q3 2025), and $3.0 million (Q2 2025).